Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 trial
Vestbo, J
Its primary mechanisms include regulating actin, a structural protein important for cell shape, movement, and division, promoting cell migration to injury sites, reducing inflammation through downregulation of pro-inflammatory cytokines, and supporting stem cell maturation and differentiation
April 22 Product: ImmunityBios Anktiva Indication: Non-muscle invasive bladder cancer A large number of bladder cancer patients will have a new treatment option as the FDA on Monday greenlit ImmunityBios Anktiva, a first-in-class IL-15 superagonist for non-muscle invasive bladder cancerwhich accounts for approximately 80% of new cases, according to the company
Further studies are needed to establish recommendations for GLP-1 RA medication use in treating gynecologic conditions
Enhanced collagen synthesis and connective tissue support [8]